Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 7;60(1):21.
doi: 10.1186/s40529-019-0270-1.

Fungal endophytes of Plumbago zeylanica L. enhances plumbagin content

Affiliations

Fungal endophytes of Plumbago zeylanica L. enhances plumbagin content

Namdeo B Andhale et al. Bot Stud. .

Abstract

Background: Plumbagin is one of the pharmaceutically important biomolecule with anticancer potential. Among the plants reported to produce plumbagin, P. zeylanica topped the list. The plumbagin production is very slow with low yield and maximum 0.5% (of dry weight) was reported in P. zeylanica. To meet the increasing demand of the plumbagin at global level, the P. zeylanica are exploited at commercial level, which may pose serious threat on the germplasm of the plant populations. So, it is needed to enhance the contents of plumbagin in P. zeylanica using biotechnological approaches. Among the various methods used to enhance the contents of plumbagin in P. zeylanica, utilization of fungal endophytes to enhance the plumbagin contents is a widely accepted approach. As fungal endophytes have the potential to synthesize various secondary metabolites and also reported to influence the synthesis of the secondary metabolites in plants. In the present study, an attempt was made to assess the effect of fungal endophytes of the Plumbago zeylanica L. on enhancement of plumbagin contents at in vivo level.

Results: Total 3 fungal endophytes were recorded from the roots of P. zeylanica collected from Khadki, Pune. The fungal endophytes were identified at morphological and molecular level. After 1 year of the treatment with fungal endophytes, significant enhancement of plumbagin was recorded in the roots of the P. zeylanica. Plumbagin contents in each were quantified against the standard plumbagin by employing LCMS-MS technique. Among the three fungal endophytes, the maximum enhancement of plumbagin content (122.67%) was reported with the treatment of Alternaria sp. (Isolate-3) in the roots of the P. zeylanica compared to control.

Conclusion: Among the three fungal endophytes, the maximum enhancement of plumbagin content (122.67%) was reported with Alternaria sp. (Isolate 3) in the roots of the pot-grown plants of P. zeylanica at in vivo level.

Keywords: Endophytic fungi; Enhancement; Plumbagin; Plumbago zeylanica; Secondary metabolites.

PubMed Disclaimer

Conflict of interest statement

The authors declare there they have no competing interests.

Figures

Fig. 1
Fig. 1
Percent enhancement of plumbagin contents in Plumbago zeylanica plants with the treatment of fungal endophytes. #Different letters over the error bars indicate the significant level of difference at 0.05 level of significance
Fig. 2
Fig. 2
Molecular phylogenetic analysis of the endophytic fungi of Plumbago zeylanica by maximum likelihood method along with the homologous ITS sequences retrieved from the gene bank (NCBI)

Similar articles

Cited by

References

    1. Ahmad I, Mehmood Z, Mohammad F. Screening of some Indian medicinal plants for their antimicrobial properties. J Ethnopharmacol. 1998;62:183–193. doi: 10.1016/S0378-8741(98)00055-5. - DOI - PubMed
    1. Aljanabi SM, Martinez I. Universal and rapid salt-extraction of high quality genomic DNA for PCR-based techniques. Nucleic Acids Res. 1997;25:4692–4693. doi: 10.1093/nar/25.22.4692. - DOI - PMC - PubMed
    1. Andhale NB, Ade AB. In vivo enhancement of Plumbagin in Plumbago zeylanica L. Germany: LAP Lambert Academic Publishing; 2013.
    1. Annonymous (2010) Repeatable delivering linear, and accurate injection volumes for UPLC and HPLC Waters Corporation (https://www.waters.com/webassets/cms/library/docs/720003445en.pdf). Accessed 24 Jan 2019
    1. Aziz MH, Dreckschmidt NE, Verma AK. Plumbagin, a medicinal plant derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res. 2008;68:9024–9032. doi: 10.1158/0008-5472.CAN-08-2494. - DOI - PMC - PubMed